Paracoccidioidomycosis classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
=== '''Latent paracoccidioides infection'''<ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969 }} </ref><ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref> === | === '''Latent paracoccidioides infection'''<ref name="pmid21738969">{{cite journal| author=Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA| title=Immunology of paracoccidioidomycosis. | journal=An Bras Dermatol | year= 2011 | volume= 86 | issue= 3 | pages= 516-24 | pmid=21738969 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21738969 }} </ref><ref name="eee">Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. ''An. Bras. Dermatol.''2013;88(5):700-711</ref> === | ||
* Patients have no clinical manifestations | * Patients have no clinical manifestations | ||
* Positive reaction to the paracoccidioidin skin test | |||
=== '''Paracoccidioides disease''' === | === '''Paracoccidioides disease''' === | ||
*'''Acute form (Juvenile)''' | *'''Acute form (Juvenile)''' | ||
**Usually affects patients under 35 years | **Usually affects patients under 35 years | ||
*'''Chronic form (Adult)''' | *'''Chronic form (Adult)''' | ||
**''Unifocal:'' Affects one organ or system | **''Unifocal:'' Affects one organ or system | ||
**''Multifocal:'' Affects two or more organs or systems | **''Multifocal:'' Affects two or more organs or systems | ||
=== '''Residual form''' (Sequela) === | === '''Residual form''' (Sequela) === | ||
*Most frequently, [[Chronic obstructive pulmonary disease|chronic pulmonary obstructive disease]] | *Most frequently, [[Chronic obstructive pulmonary disease|chronic pulmonary obstructive disease]] | ||
==References== | ==References== |
Latest revision as of 20:11, 12 February 2016
Paracoccidioidomycosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Paracoccidioidomycosis classification On the Web |
American Roentgen Ray Society Images of Paracoccidioidomycosis classification |
Risk calculators and risk factors for Paracoccidioidomycosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac
Overview
Paracoccidioidomycosis may be classified based on the onset and duration of symptoms. Paracoccidioidomycosis may be classified into: acute, subacute or chronic. The chronic form can be further subclassified into: unifocal and multifocal.[1][2]
Classification
Latent paracoccidioides infection[2][3]
- Patients have no clinical manifestations
- Positive reaction to the paracoccidioidin skin test
Paracoccidioides disease
- Acute form (Juvenile)
- Usually affects patients under 35 years
- Chronic form (Adult)
- Unifocal: Affects one organ or system
- Multifocal: Affects two or more organs or systems
Residual form (Sequela)
- Most frequently, chronic pulmonary obstructive disease
References
- ↑ de Oliveira HC, Assato PA, Marcos CM, Scorzoni L, de Paula E Silva AC, Da Silva Jde F; et al. (2015). "Paracoccidioides-host Interaction: An Overview on Recent Advances in the Paracoccidioidomycosis". Front Microbiol. 6: 1319. doi:10.3389/fmicb.2015.01319. PMC 4658449. PMID 26635779.
- ↑ 2.0 2.1 Fortes MR, Miot HA, Kurokawa CS, Marques ME, Marques SA (2011). "Immunology of paracoccidioidomycosis". An Bras Dermatol. 86 (3): 516–24. PMID 21738969.
- ↑ Marques S. Paracoccidiodomicose: atualização epidemiológica, clínica, diagnóstica e terapêutica. An. Bras. Dermatol.2013;88(5):700-711